GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 92 filers reported holding GENMARK DIAGNOSTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,328,000 | +3.8% | 108,464 | 0.0% | 0.04% | 0.0% |
| Q3 2016 | $1,279,000 | +35.6% | 108,464 | 0.0% | 0.04% | +38.5% |
| Q2 2016 | $943,000 | +65.1% | 108,464 | 0.0% | 0.03% | +85.7% |
| Q1 2016 | $571,000 | -32.3% | 108,464 | -0.1% | 0.01% | -33.3% |
| Q4 2015 | $843,000 | -1.2% | 108,572 | 0.0% | 0.02% | -16.0% |
| Q3 2015 | $853,000 | -13.3% | 108,572 | 0.0% | 0.02% | -21.9% |
| Q2 2015 | $984,000 | -30.1% | 108,572 | 0.0% | 0.03% | -42.9% |
| Q1 2015 | $1,408,000 | -4.5% | 108,572 | 0.0% | 0.06% | -1.8% |
| Q4 2014 | $1,475,000 | +51.4% | 108,572 | 0.0% | 0.06% | +16.3% |
| Q3 2014 | $974,000 | – | 108,572 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 2,730,000 | $11,384,000 | 2.77% |
| CADIAN CAPITAL MANAGEMENT, LP | 5,017,483 | $20,923,000 | 1.28% |
| Ghost Tree Capital, LLC | 500,000 | $2,085,000 | 0.49% |
| Bellevue Group AG | 773,677 | $3,226,000 | 0.34% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 180,000 | $750,000 | 0.20% |
| Penn Capital Management Company, LLC | 543,715 | $2,267,000 | 0.16% |
| HighTower Advisors, LLC | 2,355,942 | $9,826,000 | 0.08% |
| Granite Investment Partners, LLC | 215,760 | $900,000 | 0.06% |
| WRAPMANAGER INC | 39,547 | $165,000 | 0.05% |
| Alyeska Investment Group, L.P. | 1,563,881 | $6,521,000 | 0.05% |